AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Researchers analyzing 14 years of English aging-study data found that cardiovascular disease was associated with faster decline across several cognitive measures. The association varied across groups defined by long-term depressive symptom patterns, but the observational study cannot show that depression caused or prevented cognitive decline.

A 14-year observational study of 5,423 adults in England found that cardiovascular disease was associated with faster decline in memory, orientation, semantic fluency and overall cognition, while the size of the association differed across groups with distinct patterns of depressive symptoms. Published in Scientific Reports, the research describes an interaction in the observed data; it does not establish that depression causes, prevents or protects against brain aging.

The researchers used data from waves 2 through 9 of the English Longitudinal Study of Ageing, collected between 2004–2005 and 2018–2019. Participants were aged 50 or older; their mean age at the start of the analysis was 65.2, and 56% were women. Of the 5,423 people included, 1,080, or 19.9%, had cardiovascular disease at baseline.

Cardiovascular disease was based on participants’ reports of a physician diagnosis of angina, heart attack, heart failure, stroke or another heart problem. Researchers assessed depressive symptoms repeatedly with an eight-item questionnaire, then grouped participants into low-stable, moderate-stable and high-stable symptom trajectories. These categories describe reported symptoms over time; they are not clinical diagnoses of depression. The groups made up 76.8%, 18.1% and 5.1% of participants, respectively.

After accounting for a range of demographic, health and lifestyle factors, baseline cardiovascular disease was associated with an additional annual decline of 0.045 standard deviations in global cognition compared with no cardiovascular disease. The reported differences were 0.034 standard deviations per year for memory, 0.034 for semantic fluency and 0.018 for orientation. These are statistical estimates of differences in change, not predictions of how an individual’s cognition will change.

At a glance
reportWhen: Published November 2026; based on data…
The developmentA study in Scientific Reports reports that the association between cardiovascular disease and cognitive decline differed according to participants’ long-term depressive symptom trajectories.

How Heart Health Relates to Cognition

The findings add evidence that cardiovascular health and cognitive aging are linked in older adults, and suggest that the association may not look the same for everyone. The study examined several aspects of cognition rather than relying on one overall score: participants completed word-recall tests, identified the date and named animals in a timed fluency task.

Depressive symptoms also mattered in the analysis. The report says long-term symptom burden was associated with poorer cognitive performance and faster decline; people in the moderate-stable group had lower baseline global cognition, memory and semantic fluency than those in the low-stable group. The authors’ focus on symptom trajectories may help guide further research into how mental health patterns and cardiovascular conditions coincide over time.

However, the results do not show that treating depression changes the cognitive effects of heart disease, or that one condition directly produces the other. They are population-level associations from an observational study, not a basis for diagnosing an individual’s risk or changing care.

Products Worth Considering

Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor

Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor

Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking

Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking

Levoit Vital 200S-P Smart Air Purifier for Large Rooms up to 1875 ft²

Levoit Vital 200S-P Smart Air Purifier for Large Rooms up to 1875 ft²

As an affiliate, we earn on qualifying purchases.

How Researchers Tracked Change

Prior research has linked both cardiovascular disease and depressive symptoms with poorer cognitive outcomes in older adults. The study report describes possible pathways, including reduced blood flow to the brain in cardiovascular disease, but this analysis did not establish the mechanisms behind its findings.

The team used repeated cognitive assessments and symptom reports, applying statistical models to estimate cognitive change and identify symptom trajectories. Models adjusted for factors including age-related demographics, socioeconomic position, body mass index, smoking, alcohol use, physical activity, hypertension and diabetes. The analysis began with 9,432 participants, but the final group was smaller after exclusions for missing disease information, insufficient assessments and incomplete baseline data.

The study’s title describes its central question: whether long-term depressive symptom patterns modify the association between cardiovascular disease and cognitive decline. The available report says the association varied by trajectory, while also noting that the measures of depressive symptoms and cognition covered overlapping follow-up periods.

Limits of the Study’s Findings

The analysis cannot establish whether persistent depressive symptoms came before cognitive decline. Because symptom and cognitive measurements overlapped, the researchers could not determine the direction of the relationship. Nor can an observational study rule out the possibility that other factors contributed to the patterns, despite statistical adjustment.

The source report does not provide the full trajectory-specific estimates showing how the cardiovascular disease association differed across all three symptom groups. It also does not establish a biological explanation for the variation. Cardiovascular diagnoses were self-reported, and the final analysis included 5,423 of the initial 9,432 participants, so exclusions and measurement methods should be considered when interpreting the results.

Accordingly, the study supports an association, not a claim that depressive symptoms protect the brain or that depression causes cardiovascular-related cognitive decline. Its findings do not provide individual clinical guidance.

What Further Research Must Test

The study does not announce a follow-up trial or a planned next milestone. Further research would need to test whether the differing associations can be replicated and clarify the timing of depressive symptoms, cardiovascular disease and cognitive changes. Studies with measurements that establish sequence more clearly could help distinguish whether symptom patterns precede, follow or change alongside cognitive decline.

For now, the reported results are best read as evidence that cognitive aging, heart disease and depressive symptoms may be connected in complex ways, not as proof of a specific cause or intervention. The researchers’ analysis identifies questions for future work but does not test whether treating either condition changes the course of cognitive decline.

Key Questions

What did the study find?

Among 5,423 adults in England, cardiovascular disease at baseline was associated with faster average decline in global cognition, memory, orientation and semantic fluency. The association differed across groups defined by long-term depressive symptom patterns.

Does the study show that depression causes cognitive decline?

No. The research was observational and cannot establish cause and effect. Because depressive symptoms and cognition were assessed over overlapping periods, the researchers also could not establish whether symptoms preceded cognitive decline.

Were participants diagnosed with depression?

The study grouped participants by repeated scores on an eight-item depressive-symptom questionnaire. The resulting low, moderate and high trajectories describe symptom patterns and are not clinical depression diagnoses.

What does the reported annual decline mean?

For participants with cardiovascular disease, the adjusted estimate was an additional 0.045 standard deviations of annual decline in global cognition compared with those without cardiovascular disease. It is a group-level statistical estimate, not a forecast for any one person.

Can the findings guide treatment decisions?

No. The study did not test treatments or show that treating depression or cardiovascular disease changes cognitive outcomes. It reports associations that warrant further research, not individual medical advice.

Source: news-medical.net

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Patient Death Reported In Multiple Sclerosis CAR-T Study

A participant in a phase I zola-cel study died of septic pneumonia after receiving cyclophosphamide; investigators are examining the event.

Institute Of Cancer Research Surges In Global Coverage

The Institute of Cancer Research has experienced a significant surge in international media coverage, with 51 mentions in recent reports, highlighting increased global interest.

I’m A Personal Trainer And If I Only Had 15 Minutes To Build Full-body Strength, Here’s What I’d Do

Fit&Well outlines a trainer’s four-exercise dumbbell circuit for a short full-body strength session, with guidance on pacing and form.

Are Olives Raw Food? What You Should Know

Pop into the world of olives to uncover whether they truly fit into a raw food diet—discover the surprising truths that await!